Scarica l'app Stockscreener
4.255
3.28%
0.135
Rezolute Inc Borsa (RZLT) Ultime notizie
Rezolute, Inc. (NASDAQ:RZLT) is a favorite amongst institutional investors who own 77% - Yahoo
BTIG maintains $15 target on Rezolute stock following trial update - Investing.com Australia
BTIG maintains $15 target on Rezolute stock following trial update By Investing.com - Investing.com India
Rezolute Announces Completion Of Enrollment In The Phase 3 Sunrize Study Of Ersodetug In Patients With Congenital Hyperinsulinism - marketscreener.com
Rezolute complete enrollment in Phase 3 sunRIZE study of ersodetug - TipRanks
Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | - GuruFocus
Rezolute (RZLT) Completes Enrollment for Pivotal sunRIZE Study | RZLT Stock News - GuruFocus
Rezolute Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism - The Manila Times
Man Group plc Makes New $425,000 Investment in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Reports Third Quarter Fiscal 2025 Financial Results and Provides Business Update - The Globe and Mail
13 Best Multibagger Stocks to Invest in Now - Insider Monkey
Rezolute, Inc. (RZLT): Analysts See 260% Upside Potential - MSN
Rezolute, Inc. (NASDAQ:RZLT) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Rezolute Inc (NASDAQ: RZLT) Is The Hottest Stock Right Now. - Stocksregister
Balyasny Asset Management L.P. Purchases New Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
HC Wainwright Analysts Lift Earnings Estimates for Rezolute - Defense World
Wedbush Forecasts Rezolute’s FY2025 Earnings (NASDAQ:RZLT) - Defense World
Rezolute (NASDAQ:RZLT) Earns Outperform Rating from Wedbush - Defense World
Rezolute (RZLT) Advances Studies on Hyperinsulinism Treatments | - GuruFocus
Rezolute (RZLT) to Release Earnings on Wednesday - Defense World
Rezolute Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Rezolute (RZLT) Advances Studies on Hyperinsulinism Treatments | RZLT Stock News - GuruFocus
Rezolute, Inc. Reports Progress on sunRIZE Enrollment and Breakthrough Therapy Designation for Ersodetug in Hypoglycemia Treatment - Nasdaq
Rezolute Secures FDA Breakthrough Status as Phase 3 Trial Nears Full Enrollment - Stock Titan
Barclays PLC Takes Position in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com
Rezolute Gets US FDA Breakthrough Therapy Designation for Hypoglycemia Treatment - marketscreener.com
Rezolute (RZLT) Gains FDA Breakthrough Status for Hypoglycemia T - GuruFocus
FDA grants breakthrough status to Rezolute’s hypoglycemia therapy - Investing.com
FDA grants breakthrough status to Rezolute’s hypoglycemia therapy By Investing.com - Investing.com India
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism - The Manila Times
FDA Breakthrough: New Drug Shows Promise Against Life-Threatening Tumor-Induced Hypoglycemia - Stock Titan
Renaissance Technologies LLC Reduces Stake in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Inc (RZLT) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Rezolute to Participate in Upcoming Investor Conferences - The Manila Times
Rezolute: RZ402 Could Be A Surprise Candidate In The Making (NASDAQ:RZLT) - Seeking Alpha
Wedbush gives an Outperform recommendation for Rezolute Inc (RZLT) - knoxdaily.com
Market Recap: Rezolute Inc (RZLT)’s Positive Momentum, Closing at 3.86 - DWinneX
Rezolute’s $90 Million Common Stock Offering - Global Legal Chronicle
Rezolute (NASDAQ:RZLT) Given Buy Rating at HC Wainwright - Defense World
Geode Capital Management LLC Has $2.54 Million Stock Holdings in Rezolute, Inc. (NASDAQ:RZLT) - Defense World
Rezolute Closes $96.9 Million Underwritten Offering - TipRanks
Rezolute (RZLT) SunRIZE Trial Progresses Without Changes | RZLT Stock News - GuruFocus
Analysts Set Rezolute, Inc. (NASDAQ:RZLT) PT at $26.43 - Defense World
Rezolute, Inc. Announces Closing of Underwritten Offering - The Manila Times
Rezolute, Inc. Announces Closing of Underwritten Offering | RZLT Stock News - GuruFocus
Rezolute Closes Underwritten Share Offering - marketscreener.com
Rezolute, Inc. Closes $96.9 Million Offering of Common Stock and Pre-Funded Warrants - Nasdaq
Rezolute Secures Massive $97M Funding: Blackstone, Federated Hermes Back Oversubscribed Round - Stock Titan
Mintz Advises on $90 Million Underwritten Offering by Rezolute - Mintz
Rezolute gets positive recommendation from IDMC to continue Ersodetug study - MSN
1.76%
0.89%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):